David Redfern

David Redfern

Director/Board Member at ASPEN PHARMACARE HOLDINGS LIMITED

Net worth: 6 M $ as of 30/06/2026

60 year
Health Technology
Finance
Consumer Services

Profile

David Simon Redfern currently works at ViiV Healthcare Ltd., as Chairman from 2011, Human Genome Sciences, Inc., as Director from 2012, Aspen Pharmacare Holdings Ltd., as Non-Executive Director from 2015, Haleon UK Holdings Ltd., as Director, and GSK Plc, as President-Corporate Development.
Mr. Redfern also formerly worked at Haleon UK Holdings (No.2) Ltd., as Director from 2019 to 2022, GlaxoSmithKline South Africa (Pty) Ltd., as Finance Director-European Business, and PricewaterhouseCoopers Services Ltd., as Principal.
Mr. Redfern received his undergraduate degree from the University of Bristol.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
GSK PLC
0.01%
13/07/2026 2,25,304 ( 0.01% ) 6 M $ 30/06/2026

David Redfern active positions

CompaniesPositionStart
GSK PLC Corporate Officer/Principal 01/05/2008
ASPEN PHARMACARE HOLDINGS LIMITED Director/Board Member 01/02/2015
Chairman 01/04/2011
Director/Board Member 30/07/2012
Director/Board Member -

Former positions of David Redfern

CompaniesPositionEnd
Director/Board Member 18/07/2022
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of David Redfern's experience

Training of David Redfern

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

71

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Commercial Services

Health Technology

Finance

Finance